Devinder Singh Dhindsa

Devinder Dhindsa practices at St. Francis - Emory Healthcare in Columbus, Georgia, part of ScionHealth.

Devinder Dhindsa's NPI, 1265828610, was assigned on April 13, 2015. Devinder Dhindsa graduated from George Washington University School of Medicine in 2015. Devinder Dhindsa holds Georgia license 80712.

Devinder Dhindsa's primary practice is St. Francis - Emory Healthcare, at 2122 Manchester Expressway, Columbus, GA 31995 in Muscogee County. The practice phone is (706) 596-4020.

Devinder Dhindsa's primary practice is St. Francis - Emory Healthcare in Columbus, Georgia, part of ScionHealth. Devinder Dhindsa is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Devinder Dhindsa to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Devinder Dhindsa practices, 5 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Devinder Dhindsa's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Devinder Dhindsa is licensed in Georgia.

CMS data shows 213 Medicare services from Devinder Dhindsa across 8 procedure codes in 2024, for 147 Medicare patients. Medicare paid $13,165 for them.

CMS counts 147 Medicare patients who saw Devinder Dhindsa in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Devinder Dhindsa's median patient age at 74, with 42% women.

In 2024, Devinder Dhindsa wrote 33 Medicare Part D claims for 20 patients. 91% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $244 in total drug cost. In 2022, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Devinder Dhindsa for performance year 2024, reported through an alternative payment model (APM). Devinder Dhindsa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Devinder Dhindsa as offering telehealth. CMS counts 43 procedures of pacemaker insertion or repair by Devinder Dhindsa, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 41 papers to Devinder Dhindsa, published from 2016 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Cardiovascular Diseases, Coronary Artery Disease and Cholesterol, HDL. Devinder Dhindsa has published most often in Am J Cardiol. Devinder Dhindsa's most frequent co-authors are Laurence S. Sperling, MD, Arshed A. Quyyumi, MD and Anurag Mehta, MD.

CMS Open Payments shows 267 general payments to Devinder Dhindsa from 9 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 41% of the total. Abbott Laboratories paid the most, $18,931.

Devinder Dhindsa graduated from George Washington University School of Medicine in 2015.